NATURADE INC
NT 10-K, 2000-03-30
PHARMACEUTICAL PREPARATIONS
Previous: NATIONAL BANKSHARES INC, 10-K, 2000-03-30
Next: BALDWIN PIANO & ORGAN CO /DE/, 10-K, 2000-03-30



                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                   FORM 12b-25

                           Notification of Late Filing

                                               Commission File Number  33-7106-A
                                                                       ---------
(CHECK ONE):
[X] Form 10-K and Form 10-KSB [ ] FORM 11-K [ ] FORM 20-F [X] FORM 10-Q and Form
10-QSB [ ] Form N-SAR

        For Period Ended:  December 31, 1999
                          ------------------


[ ] Transition Report on Form 10-K and Form 10-KSB
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q and Form 10-QSB
[ ] Transition Report on Form N-SAR

        For the transition period ended: ____________________

        Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.

        If the  notification  relates to a portion of the filing  checked above,
identify the item(s) to which the notification relates:


                                     PART I
                             REGISTRANT INFORMATION

        Full name of registrant         NATURADE, INC.
                               --------------------------------------------

        Former name if applicable

        ------------------------------------------------------------------------

        Address of principal executive office:  14370 Myford Rd.
                                                ----------------

        City, State and Zip Code:  Irvine, California 92606
                                   ------------------------



<PAGE>

                                     PART II
                            RULES 12b-25 (b) and (c)

        If the subject report could not be filed without  unreasonable effort or
expense  and  the  registrant  seeks  relief  pursuant  to Rule  12b-25(b),  the
following should be completed. (Check appropriate box.)

        [X] (a) The reasons  described in reasonable  detail in Part III of this
form could not be eliminated without unreasonable effort or expense;

        [X] (b) The subject annual report, semi-annual report, transition report
on forms 10-K,  10-KSB,  20-F,  11-K or Form N-SAR,  or portion  thereof will be
filed on or before the 15th calendar day following the  prescribed  due date; or
the subject  quarterly  report or  transition  report on Form 10-Q,  10-QSB,  or
portion  thereof will be filed on or before the fifth calendar day following the
prescribed due date; and

        [ ] (c) The  accountant's  statement  or other  exhibit  required  by
Rule 12b-25(c) has been attached if applicable.

                                    PART III
                                    NARRATIVE

        State below in reasonable detail the reasons why the Form 10-K,  10-KSB,
11-K, 20-F, 10-Q,  10-QSB,  N-SAR or the transition  report thereof could not be
filed within the prescribed time period.

The Registrant and its auditors are in the process of analyzing the Registrant's
present access to credit in light of its future working capital requirements and
will not be able to complete this analysis (and the corresponding effect of this
analysis on disclosures in the  Registrant's  Annual Report on Form 10-K) within
the prescribed time period without unreasonable effort or expense.

                                     PART IV
                                OTHER INFORMATION
        (1)    Name and telephone number of person to contact in regard to this
notification.

                  Lawrence J. Batina    714           573-4800
                  -------------------------------------------------
                  (NAME)            (AREA CODE)  (TELEPHONE NUMBER)

        (2)    Have all  other periodic reports  required under  Section 13  or
15(d) of the  Securities  Exchange  Act of 1934 or Section 30 of the  Investment
Company Act of 1940 during the  preceding 12 months or for such  shorter  period
that the  registrant  was  required to file such  report(s)  been filed?  If the
answer is no, identify report(s). [X] YES [ ] NO

        (3)    Is  it  anticipated  that  any  significant change in results  of
operations  from the  corresponding  period  for the last  fiscal  year  will be
reflected by the  earnings  statements  to be included in the subject  report or
portion thereof? [X] YES [ ] NO

<PAGE>




        If so: attach an explanation of the anticipated change, both narratively
and  quantitatively,  and, if  appropriate,  state the reasons why a  reasonable
estimate of the results cannot be made.

        The  Registrant  anticipates a loss from  operations for the fiscal year
ended December 31, 1999 of approximately $9.7 million compared to a loss from
operations for the fiscal year ended September 30, 1998 of $4.1 million. The
primary factors contributing to the loss in the 1999 fiscal year are 1) $1.6
million sales decline, 2) $1 million write-off of intangible assets, 3) $1.9
million settlement of a legal judgment, 4) $1.5 million of non-cash interest
charges related to the conversion feature of debt borrowed from a majority
shareholder and $0.4 million related to warrant grants and 5) elimination of
$0.9 million of obsolete inventory.


































<PAGE>



                                 NATURADE, INC.

        Has  caused  this  notification  to be  signed  on  its  behalf  by  the
undersigned thereunto duly authorized.

Date    March 30, 2000                 By   /s/ Lawrence J. Batina
    ---------------------                ---------------------------------------
                                            Lawrence J. Batina
                                            Chief Financial Officer
                                            Naturade, Inc.


                                    ATTENTION

      Intentional misstatements or omissions of fact constitute Federal criminal
violations (see 18 U.S.C. 1001).



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission